Alpha Tau Medical Ltd. Ordinary Shares earnings per share and revenue
On Nov 20, 2025, DRTS reported earnings of -0.14 USD per share (EPS) for Q3 25, missing the estimate of -0.11 USD, resulting in a -19.05% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +10.09% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Jan 06, 2026 For Q2 26
Estimate
-$0.10
Actual
$0.00
Surprise
+100.00%
FAQ
What were Alpha Tau Medical Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Alpha Tau Medical Ltd. Ordinary Shares reported EPS of -$0.14, missing estimates by -19.05%, and revenue of $0.00, 0% as expectations.
How did the market react to Alpha Tau Medical Ltd. Ordinary Shares's Q3 2025 earnings?
The stock price moved up 10.09%, changed from $3.47 before the earnings release to $3.82 the day after.
When is Alpha Tau Medical Ltd. Ordinary Shares expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Alpha Tau Medical Ltd. Ordinary Shares's next earnings report?
Based on --
analysts, Alpha Tau Medical Ltd. Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.